PRE 14A

PRELIMINARY PROXY STATEMENT

Company: RELMADA THERAPEUTICS, INC.
Filed: December 21, 2018
Period of Report: December 21, 2018
Accession Number: 0001213900-18-017725

View Document ↗ View on SEC.gov ↗